Aetna CPB 0070 Updated: What Billing Teams Need to Know About Diabetes Tests, Programs, and Supplies Coverage in 2026

Aetna has issued a modification to Clinical Policy Bulletin 0070, covering diabetes tests, programs, and supplies, with an effective date of February 21, 2026. This policy governs coverage criteria for a broad range of diabetes-related services—from blood glucose monitoring equipment and continuous glucose monitors (CGMs) to diabetes self-management training (DSMT) programs and related supplies. If your practice bills for endocrinology, primary care, or durable medical equipment in the diabetes space, this update warrants a close look at your current workflows and documentation practices.

What Changed in Aetna's CPB 0070 Diabetes Coverage Policy

Aetna, a CVS Health company, has modified CPB 0070 — one of its most consequential clinical policy bulletins for practices that treat patients with Type 1 or Type 2 diabetes. CPB 0070 is a broad, multi-category policy that has historically addressed coverage for self-monitoring blood glucose (SMBG) equipment, continuous glucose monitoring systems, insulin pumps and supplies, and structured diabetes education programs.

Because no line-level policy detail was available at the time of publication, the specific language changes in this February 2026 revision have not been publicly summarized. However, given the scope of CPB 0070 and the current regulatory environment around diabetes technology and education, billing teams should understand what this policy typically governs and where changes most commonly occur.

What Aetna CPB 0070 Covers: A Policy Overview

CPB 0070 has historically organized diabetes-related coverage into several distinct categories. Understanding those categories is essential for knowing which claims are most likely to be affected by any modification.

Blood Glucose Monitoring Equipment and Supplies
Coverage for SMBG devices and test strips is typically tied to a confirmed diabetes diagnosis and physician attestation of medical necessity. Prior authorization may apply for high-volume test strip quantities, particularly for members on non-insulin therapies.

Continuous Glucose Monitoring (CGM) Systems
CGM coverage under this policy has been an active area of revision across multiple payers over the past two years. Aetna has historically required criteria such as Type 1 or insulin-dependent Type 2 diabetes, frequent dose adjustments, and ordering by or in consultation with an endocrinologist or diabetes specialist. Given ongoing CGM expansion—including CMS's recent decision to broaden Medicare CGM coverage—commercial policy updates in this space are expected.

Insulin Pumps and Associated Supplies
Coverage for external insulin infusion pumps (often billed under HCPCS codes in the E-series range) typically requires documentation of inadequate glycemic control on multiple daily injections, specific HbA1c thresholds, and patient training completion. Prior authorization is standard.

Diabetes Self-Management Training (DSMT)
Structured DSMT programs are covered when provided by an accredited program (typically ADA or ADCES-recognized) with a referring physician order. Initial and follow-up education hours are typically defined, and diagnosis codes must clearly support the medical necessity of ongoing education.

Therapeutic Continuous Glucose Monitoring
Distinctions between "professional CGM" (practice-owned, retrospective review) and "personal CGM" (patient-worn, real-time) affect both coverage and billing pathways. Modifications to this section of CPB 0070 are a common source of claim denials when teams apply outdated criteria.

Affected Codes

The February 2026 update to CPB 0070 does not list specific CPT or HCPCS codes in the data available for this post. The full policy document—including all covered codes, not-covered codes, and applicable ICD-10 diagnosis codes—is available through the source document at app.payerpolicy.org/p/aetna/0070.

Billing teams should access the full CPB 0070 document directly to confirm the current code lists before submitting claims. Code tables within this policy have historically included codes across the following categories:

• CPT codes for diabetes education and training services
• HCPCS A-codes and E-codes for glucose monitors, test strips, CGM sensors and transmitters, and insulin pumps
• HCPCS K-codes for certain DME supplies
• ICD-10-CM codes in the E10–E13 range (Type 1, Type 2, and other specified diabetes mellitus) used to establish medical necessity

Do not use historical code lists as a substitute for reviewing the current policy version. This is particularly important for CGM-related HCPCS codes, which have seen significant additions and reclassifications industry-wide.

Prior Authorization Requirements Under Aetna CPB 0070

Prior authorization has historically been required for insulin pumps, CGM systems, and structured diabetes education programs under Aetna commercial plans. The specific PA requirements can vary by plan type (HMO vs. PPO), member benefit design, and whether the plan is fully insured or self-funded.

For DME suppliers and specialty pharmacies, obtaining PA before dispensing CGM sensors or insulin pump supplies remains critical. Retroactive authorization requests for these categories have low approval rates, and missing the initial auth is one of the most common sources of preventable revenue loss in this category.

What Your Billing Team Should Do